HLB테라퓨틱스: directors' dealings · South Korea · DART (FSS)

Explore the full management transaction log of HLB테라퓨틱스, a listed equity based in South Korea. Shares are listed on KR KR, under the supervision of DART (FSS). Operating in the Healthcare sector, HLB테라퓨틱스 has recorded 9 insider filings. Market capitalisation: €264.9bn. The latest transaction was disclosed on 11 March 2026 (Purchase). Among the most active insiders: HLB. Every trade is accessible without an account.